2017 International Congress Archives - Page 114 of 155

Prevalence of substance abuse in Huntington´s disease patients and its relationship with neuropsychiatric symptoms

K. SALINAS BARBOZA, L. MENDOZA VEGA, A. CRUZ LANDERO, S. ISAIS MILLAN, M. RODRIGUEZ VIOLANTE, A. CERVANTES ARRIAGA, N. DAVILA AVILA (MEXICO, Mexico)
Prevalence of tremor in Multiple Sclerosis in Isfahan, Iran

M. Salari, M. Etemadifar, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)
Prevelance,clinical pathology and Treatment of Dystonia in Pakistani Population

S. Naureen, A. Arshad, N. Ahmad (RAWALPINDI, Pakistan)
Preventing Levodopa Induced Dyskinesia with Docosohexanoid Acid in Parkinson Disease

K. Chung, B. Lobb (Portland, OR, USA)
Primary progressive apraxia: an unusual ideomotor syndrome

Y. Fernandez, S. Frucht (New York, NY, USA)
Prism adaptation and cerebellar inhibition were impaired in essential tremor

R. Hanajima, R. Tsutsumi, Y. Shirota, T. Shimizu, N. Tanaka, Y. Ugawa (Kanagawa, Japan)
Pro-saccades predict decline in attention over 18months in newly diagnosed Parkinson’s disease

S. Stuart, L. Alcock, J. Nell, R. Lawson, R. Morris, A. Yarnall, D. Burn, L. Rochester (Newcastle Upon Tyne, United Kingdom)
Probabilistic mapping of deep brain stimulation in Parkinson’s disease.

T. Dembek, J. Roediger, V. Visser-Vandewalle, L. Timmermann, M. Barbe (Cologne, Germany)
Probiotic correction of intestinal dysbiosis in Parkinson’s disease

I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)
Prof. Wadia’s contributions to neurology and SCA2

F. Tensini, J. Pedroso, O. Barsottini, H. Teive (Curiitiba, Brazil)